Study Details
Full Title
Phase 2, double-blind, placebo-controlled study to evaluate the effectiveness of two doses of AP-472 as adjunctive therapy to levodopa in Parkinson’s disease (PD) participants with motor fluctuations
Principal Investigator
Kathryn
Moore
Protocol Number
PRO00119836
NCT ID
NCT07432958
Phase
II
Enrollment Status
Open to Enrollment